{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T14:18:30Z","timestamp":1794752310756,"version":"4.9.1"},"reference-count":152,"publisher":"Elsevier","isbn-type":[{"value":"9780443192944","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.acc.2023.08.004","type":"book-chapter","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:05:26Z","timestamp":1695729926000},"page":"103-161","source":"Crossref","is-referenced-by-count":6,"title":["Advances in preeclampsia testing"],"prefix":"10.1016","author":[{"given":"Jessica J.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.acc.2023.08.004_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009382","article-title":"Hypertensive disorders of pregnancy and future maternal cardiovascular risk","volume":"7","author":"Ying","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/bs.acc.2023.08.004_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.14540","article-title":"Hypertensive disorders of pregnancy and long-term cardiovascular health: FIGO best practice advice","volume":"160","author":"Poon","year":"2023","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/bs.acc.2023.08.004_bib3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review","volume":"367","author":"Khan","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2023.08.004_bib4","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/10641950601147945","article-title":"Population-based analysis of hypertensive disorders in pregnancy","volume":"26","author":"Lawler","year":"2007","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/bs.acc.2023.08.004_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/bs.acc.2023.08.004_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.emc.2019.01.008","article-title":"Hypertensive disorders of pregnancy","volume":"37","author":"Wilkerson","year":"2019","journal-title":"Emerg. Med. Clin. N. Am."},{"key":"10.1016\/bs.acc.2023.08.004_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11906-015-0563-z","article-title":"Secondary hypertension in pregnancy","volume":"17","author":"Malha","year":"2015","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/bs.acc.2023.08.004_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/bs.acc.2023.08.004_bib10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jogc.2022.03.002","article-title":"Guideline no. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management","volume":"44","author":"Magee","year":"2022","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/bs.acc.2023.08.004_bib11","doi-asserted-by":"crossref","unstructured":"Hypertension in pregnancy: executive summary. Obstet. Gynecol. 122 (2013) 1122\u20131131.","DOI":"10.1097\/01.AOG.0000437382.03963.88"},{"key":"10.1016\/bs.acc.2023.08.004_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0002-9378(00)70216-X","article-title":"Eclampsia. VIII. Risk factors for maternal morbidity","volume":"182","author":"Mattar","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib13","first-page":"121","article-title":"Hypertensive disorders of pregnancy","volume":"93","author":"Leeman","year":"2016","journal-title":"Am. Fam. Phys."},{"key":"10.1016\/bs.acc.2023.08.004_bib14","doi-asserted-by":"crossref","first-page":"S1182","DOI":"10.1016\/j.ajog.2020.11.029","article-title":"Chronic hypertension and superimposed preeclampsia: screening and diagnosis","volume":"226","author":"Kametas","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib15","doi-asserted-by":"crossref","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","article-title":"The etiology of preeclampsia","volume":"226","author":"Jung","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib16","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia","volume":"124","author":"Rana","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/bs.acc.2023.08.004_bib17","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"Powe","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2023.08.004_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","article-title":"Pre-eclampsia","volume":"398","author":"Chappell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2023.08.004_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.23937\/2474-3690\/1510024","article-title":"Preeclampsia: pathophysiology and the maternal-fetal risk","volume":"3","author":"Khalil","year":"2017","journal-title":"J. Hypertens. Manag."},{"key":"10.1016\/bs.acc.2023.08.004_bib20","doi-asserted-by":"crossref","first-page":"S954","DOI":"10.1016\/j.ajog.2020.10.024","article-title":"The placenta and preeclampsia: villain or victim?","volume":"226","author":"Melchiorre","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02630","article-title":"The immunogenetic conundrum of preeclampsia","volume":"9","author":"Lokki","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/bs.acc.2023.08.004_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01659","article-title":"Disruption in the regulation of immune responses in the placental subtype of preeclampsia","volume":"9","author":"Geldenhuys","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/bs.acc.2023.08.004_bib23","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3109\/14767058.2014.976198","article-title":"The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortion","volume":"28","author":"Kim","year":"2015","journal-title":"J. Matern.-Fetal Neonatal Med."},{"key":"10.1016\/bs.acc.2023.08.004_bib24","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMra2109523","article-title":"Preeclampsia","volume":"386","author":"Magee","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2023.08.004_bib25","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14710","article-title":"Physical activity differentially regulates VEGF, PlGF, and their receptors in the human placenta","volume":"9","author":"Bhattacharjee","year":"2021","journal-title":"Physiol. Rep."},{"key":"10.1016\/bs.acc.2023.08.004_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/hr.2016.152","article-title":"Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction","volume":"40","author":"Tomimatsu","year":"2017","journal-title":"Hypertens. Res."},{"key":"10.1016\/bs.acc.2023.08.004_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.acc.2023.08.004_bib28","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/jc.2002-021942","article-title":"Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia","volume":"88","author":"Koga","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2023.08.004_bib29","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1210\/jc.2003-030528","article-title":"Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences","volume":"88","author":"Tsatsaris","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2023.08.004_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000368605","article-title":"Update on the pathophysiological implications and clinical role of angiogenic factors in pregnancy","volume":"37","author":"Llurba","year":"2015","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/bs.acc.2023.08.004_bib31","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/jhh.2017.61","article-title":"Placental growth factor and pre-eclampsia","volume":"31","author":"Chau","year":"2017","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/bs.acc.2023.08.004_bib32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrneph.2016.21","article-title":"Testing for pre-eclampsia: paving the way to early diagnosis","volume":"12","author":"Benzing","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/bs.acc.2023.08.004_bib33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2215\/CJN.03761106","article-title":"Pathophysiology of the clinical manifestations of preeclampsia","volume":"2","author":"Hladunewich","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2023.08.004_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2023.08.004_bib35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine","volume":"77","author":"Dr\u00f6ge","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/bs.acc.2023.08.004_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101861","article-title":"Role of oxidative stress in the dysfunction of the placental endothelial nitric oxide synthase in preeclampsia","volume":"40","author":"Guerby","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/bs.acc.2023.08.004_bib37","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jacc.2020.08.014","article-title":"Preeclampsia\u2014pathophysiology and clinical presentations: JACC state-of-the-art review","volume":"76","author":"Ives","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/bs.acc.2023.08.004_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00563","article-title":"Causes and consequences of the dysregulated maternal renin-angiotensin system in preeclampsia","volume":"10","author":"Lumbers","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/bs.acc.2023.08.004_bib39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2174\/1389201019666180925121254","article-title":"The role of agonistic autoantibodies to the angiotensin ii type 1 receptor (AT1-AA) in pathophysiology of preeclampsia","volume":"19","author":"Campbell","year":"2018","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/bs.acc.2023.08.004_bib40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.mnh.0000436545.94132.52","article-title":"Renal function in normal and disordered pregnancy","volume":"23","author":"Hussein","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/bs.acc.2023.08.004_bib41","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/j.1523-1755.2005.00316.x","article-title":"Preeclampsia: a renal perspective","volume":"67","author":"Karumanchi","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/bs.acc.2023.08.004_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/176973","article-title":"Renal involvement in preeclampsia: similarities to VEGF ablation therapy","volume":"2011","author":"M\u00fcller-Deile","year":"2011","journal-title":"J. Pregnancy"},{"key":"10.1016\/bs.acc.2023.08.004_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40620-016-0342-1","article-title":"Prevalence of chronic kidney disease after preeclampsia","volume":"30","author":"Lopes van Balen","year":"2017","journal-title":"J. Nephrol."},{"key":"10.1016\/bs.acc.2023.08.004_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11906-019-0961-8","article-title":"Pathophysiology of cerebral vascular dysfunction in pregnancy-induced hypertension","volume":"21","author":"Younes","year":"2019","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/bs.acc.2023.08.004_bib45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/AOG.0000000000001758","article-title":"Preeclampsia and long-term risk of maternal retinal disorders","volume":"129","author":"Auger","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib46","doi-asserted-by":"crossref","first-page":"673","DOI":"10.31128\/AJGP-10-19-5113","article-title":"Ophthalmic associations in pregnancy","volume":"49","author":"Qin","year":"2020","journal-title":"Aust. J. Gen. Pract."},{"key":"10.1016\/bs.acc.2023.08.004_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cld.409","article-title":"Preeclampsia-induced liver dysfunction, HELLP syndrome, and acute fatty liver of pregnancy","volume":"4","author":"Hammoud","year":"2014","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/bs.acc.2023.08.004_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114488","article-title":"Blood coagulation parameters and platelet indices: changes in normal and preeclamptic pregnancies and predictive values for preeclampsia","volume":"9","author":"Han","year":"2014","journal-title":"Plos One"},{"key":"10.1016\/bs.acc.2023.08.004_bib49","article-title":"Coagulation profile and platelet parameters in pregnancy induced hypertension cases and normotensive pregnancies: a cross-sectional study","volume":"80","author":"Bhutani","year":"2022","journal-title":"Ann. Med. Surg. (Lond.)"},{"key":"10.1016\/bs.acc.2023.08.004_bib50","unstructured":"Nice Guideline [NG133]. Hypertension in Pregnancy: Diagnosis and Management. \u3008https:\/\/www.nice.org.uk\/guidance\/ng133\u3009 (accessed January 20)."},{"key":"10.1016\/bs.acc.2023.08.004_bib51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 international society for the study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/bs.acc.2023.08.004_bib52","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jogc.2022.03.002","article-title":"Guideline no. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management","volume":"44","author":"Magee","year":"2022","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/bs.acc.2023.08.004_bib53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jalm\/jfaa149","article-title":"A critical review on the use of race in understanding racial disparities in preeclampsia","volume":"6","author":"Fasanya","year":"2021","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/bs.acc.2023.08.004_bib54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(10)61351-7","article-title":"Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullpiers model","volume":"377","author":"von Dadelszen","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2023.08.004_bib55","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/1471-0528.16319","article-title":"A core outcome set for pre-eclampsia research: an international consensus development study","volume":"127","author":"Duffy","year":"2020","journal-title":"BJOG: Int. J. Obstet. Gynaecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib56","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/HYPERTENSIONAHA.117.10318","article-title":"Assessment of the fullpiers risk prediction model in women with early-onset preeclampsia","volume":"71","author":"Ukah","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/bs.acc.2023.08.004_bib57","article-title":"A comparative analysis of neonatal outcomes in pregnancies complicated by preeclampsia and eclampsia in Ghana","volume":"2","author":"Lawrence","year":"2022","journal-title":"AJOG Glob. Rep."},{"key":"10.1016\/bs.acc.2023.08.004_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101625","article-title":"Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring","volume":"8","author":"Fox","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/bs.acc.2023.08.004_bib59","doi-asserted-by":"crossref","first-page":"S1108","DOI":"10.1016\/j.ajog.2020.08.045","article-title":"Prevention of preeclampsia with aspirin","volume":"226","author":"Rolnik","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib60","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.placenta.2015.01.004","article-title":"Aspirin inhibits expression of sFlt1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1","volume":"36","author":"Li","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/bs.acc.2023.08.004_bib61","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027916","article-title":"Aspirin in the prevention of preeclampsia: a protocol for systematic review and meta analysis","volume":"100","author":"Mkhize","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/bs.acc.2023.08.004_bib62","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2023.08.004_bib63","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/bs.acc.2023.08.004_bib64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O\u2019Gorman","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib65","series-title":"Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy","article-title":"National Institute for Health and Clinical Excellence: guidance","year":"2010"},{"key":"10.1016\/bs.acc.2023.08.004_bib66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000338470","article-title":"A competing risks model in early screening for preeclampsia","volume":"32","author":"Wright","year":"2012","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/bs.acc.2023.08.004_bib67","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/uog.5402","article-title":"Uterine artery doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia","volume":"32","author":"Plasencia","year":"2008","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib68","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1038\/s41598-020-61830-5","article-title":"First trimester PAPP-A serum levels and long-term metabolic outcome of mothers and their offspring","volume":"10","author":"Fruscalzo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.acc.2023.08.004_bib69","article-title":"Association of low maternal pregnancy-associated plasma protein a with adverse perinatal outcome","volume":"11","author":"Antsaklis","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/bs.acc.2023.08.004_bib70","first-page":"103","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O'Gorman","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib71","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG committee opinion: low-dose aspirin use during pregnancy","volume":"132","author":"Society for maternal fetal medicine","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib72","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF03401381","article-title":"Thyroid diseases during pregnancy: a number of important issues","volume":"14","author":"Krassas","year":"2015","journal-title":"Hormones (Athens, Greece)"},{"key":"10.1016\/bs.acc.2023.08.004_bib73","first-page":"g4929","article-title":"Diagnosis and management of subclinical hypothyroidism in pregnancy","volume":"349","author":"Negro","year":"2014","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/bs.acc.2023.08.004_bib74","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/10641955.2020.1800030","article-title":"Hypothyroidism and the increased risk of preeclampsia - interpretative factors?","volume":"39","author":"Lintula","year":"2020","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/bs.acc.2023.08.004_bib75","unstructured":"NICE Hypertension in Pregnancy: Planning Care for Women at Moderate and High Risk of Pre-eclampsia. \u3008https:\/\/www.nice.org.uk\/guidance\/ng133\/resources\/planning-care-for-women-at-moderate-and-high-risk-of-preeclampsia-pdf-8720711390\u3009."},{"key":"10.1016\/bs.acc.2023.08.004_bib76","unstructured":"American College of Obstetricians and Gynecologists Low-dose Aspirin Use During Pregnancy. \u3008https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2018\/07\/low-dose-aspirin-use-during-pregnancy\u3009."},{"key":"10.1016\/bs.acc.2023.08.004_bib77","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation: comparison with NICE guidelines and acog recommendations","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib78","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/uog.20105","article-title":"ISUOG practice guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia","volume":"53","author":"Sotiriadis","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The international federation of gynecology and obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"5","key":"10.1016\/bs.acc.2023.08.004_bib80","first-page":"1","article-title":"First-trimester screening program for the risk of pre-eclampsia using a multiplemarker algorithm: a health technology assessment","volume":"22","author":"Ontario Health","year":"2022","journal-title":"Ont. Health Technol. Assess. Ser. [internet]"},{"key":"10.1016\/bs.acc.2023.08.004_bib81","unstructured":"NICEPlGF-based testing to help diagnose suspected preterm pre-eclampsia. Dg49 2022."},{"key":"10.1016\/bs.acc.2023.08.004_bib82","unstructured":"NICEPlGF-based testing to help diagnose suspected pre-eclampsia 2016 Dg23."},{"key":"10.1016\/bs.acc.2023.08.004_bib83","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/uog.19051","article-title":"Comparison of three commercially available placental growth factor-based tests in women with suspected preterm pre-eclampsia: the compare study","volume":"53","author":"McCarthy","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib84","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.preghy.2020.04.005","article-title":"Rule-in thresholds for DELFIA Xpress PlGF 1-2-3 test for suspected pre-eclampsia","volume":"21","author":"Giblin","year":"2020","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/bs.acc.2023.08.004_bib85","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.preghy.2021.12.008","article-title":"Rule-in and rule-out of pre-eclampsia using DELFIA Xpress PlGF 1-2-3 and sFlt-1: PlGF ratio","volume":"27","author":"Bremner","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/bs.acc.2023.08.004_bib86","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/bs.acc.2023.08.004_bib87","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","article-title":"Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial","volume":"393","author":"Duhig","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2023.08.004_bib88","unstructured":"Roche Elecsys sFlt-1 package insert. 2018-11, v 9.0 english."},{"key":"10.1016\/bs.acc.2023.08.004_bib89","unstructured":"Roche Elecsys PlGF package insert. 2019-08, v 10.0 english."},{"key":"10.1016\/bs.acc.2023.08.004_bib90","series-title":"Methods in Molecular Biology","first-page":"355","article-title":"Preeclampsia methods and protocols","year":"2017"},{"key":"10.1016\/bs.acc.2023.08.004_bib91","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jalm\/jfab135","article-title":"Analytical performance and quality indicators of fully automated immunoassays for sFlt-1 and PlGF","volume":"7","author":"Higgins","year":"2022","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/bs.acc.2023.08.004_bib92","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.clinbiochem.2010.02.010","article-title":"Multicenter evaluation of the first automated elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia","volume":"43","author":"Schiettecatte","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/bs.acc.2023.08.004_bib93","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/HYPERTENSIONAHA.119.12760","article-title":"Short-term prediction of adverse outcomes using the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor) ratio in asian women with suspected preeclampsia","volume":"74","author":"Bian","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/bs.acc.2023.08.004_bib94","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","article-title":"Randomized interventional study on prediction of preeclampsia\/eclampsia in women with suspected preeclampsia: inspire","volume":"74","author":"Cerdeira","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/bs.acc.2023.08.004_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156013","article-title":"Influence of the sFlt-1\/PlGF ratio on clinical decision-making in women with suspected preeclampsia","volume":"11","author":"Klein","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2023.08.004_bib96","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2023.08.004_bib97","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.preghy.2020.10.005","article-title":"Placental growth factor measurements in the assessment of women with suspected preeclampsia: a stratified analysis of the parrot trial","volume":"23","author":"Duhig","year":"2021","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/bs.acc.2023.08.004_bib98","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.021376","article-title":"Decision threshold for Kryptor sFlt-1\/PlGF ratio in women with suspected preeclampsia: retrospective study in a routine clinical setting","volume":"10","author":"Andersen","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/bs.acc.2023.08.004_bib99","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/10641955.2016.1148162","article-title":"Kryptor-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes","volume":"35","author":"Salahuddin","year":"2016","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/bs.acc.2023.08.004_bib100","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200161","article-title":"Circulating angiogenic factor levels in hypertensive disorders of pregnancy","volume":"1","author":"Thadhani","year":"2022","journal-title":"NEJM Evid."},{"key":"10.1016\/bs.acc.2023.08.004_bib101","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.preghy.2020.03.002","article-title":"Correlation of Kryptor and Elecsys\u00ae immunoassay sFlt-1\/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: a case-control study","volume":"20","author":"Sim\u00f3n","year":"2020","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/bs.acc.2023.08.004_bib102","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jalm\/jfad003","article-title":"Clinical validation of the sFlt-1:PlGF ratio as a biomarker for preeclampsia diagnosis in a high-risk obstetrics unit.","volume":"8","author":"Miller","year":"2023","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/bs.acc.2023.08.004_bib103","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/s41440-021-00629-x","article-title":"Short-term prediction of preeclampsia using the sFlt-1\/PlGF ratio: a subanalysis of pregnant japanese women from the prognosis asia study","volume":"44","author":"Ohkuchi","year":"2021","journal-title":"Hypertens. Res."},{"key":"10.1016\/bs.acc.2023.08.004_bib104","doi-asserted-by":"crossref","first-page":"S1037","DOI":"10.1016\/j.ajog.2020.10.028","article-title":"Real-world data on the clinical use of angiogenic factors in pregnancies with placental dysfunction","volume":"226","author":"Dathan-Stumpf","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib105","unstructured":"Perkin\/Elmer DELFIA Xpress PlGF 1-2-3 assay package insert. Version 13907817-4 (en)."},{"key":"10.1016\/bs.acc.2023.08.004_bib106","unstructured":"Perkin\/Elmer DELFIA\/AutoDELFIA PlGF 1-2-3 assay package insert. Version 13908271-2 (en). B055-301."},{"key":"10.1016\/bs.acc.2023.08.004_bib107","unstructured":"Perkin\/Elmer DELFIA Xpress sFlt-1 kit package insert. Version 13908535-4 (en). 6009-0010\/6009-001c."},{"key":"10.1016\/bs.acc.2023.08.004_bib108","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/pd.2894","article-title":"Stability of first trimester placental growth factor in serum and whole blood","volume":"31","author":"Cowans","year":"2011","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2023.08.004_bib109","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.placenta.2019.08.086","article-title":"Reference centiles for maternal placental growth factor levels at term from a low-risk population","volume":"86","author":"Dunn","year":"2019","journal-title":"Placenta"},{"key":"10.1016\/bs.acc.2023.08.004_bib110","article-title":"The use of biochemical and biophysical markers in early screening for preeclampsia in mongolia","volume":"6","author":"Tserensambuu","year":"2018","journal-title":"Med. Sci. (Basel)"},{"key":"10.1016\/bs.acc.2023.08.004_bib111","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.preghy.2017.12.009","article-title":"Analytical validation of soluble fms-like tyrosine and placental growth factor assays on BRAHMS Kryptor compact plus automated immunoassay platform","volume":"11","author":"Chan","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/bs.acc.2023.08.004_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2019.08.001","article-title":"Stability of placental growth factor, soluble fms-like tyrosine kinase 1, and soluble fms-like tyrosine kinase 1 e15a in human serum and plasma","volume":"86","author":"Rowson","year":"2019","journal-title":"Placenta"},{"key":"10.1016\/bs.acc.2023.08.004_bib113","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajog.2011.07.037","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","volume":"206","author":"Verlohren","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib114","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1471-2393-13-161","article-title":"Comparison of placental growth factor and fetal flow doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational study","volume":"13","author":"Molvarec","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/bs.acc.2023.08.004_bib115","unstructured":"Quidel Triage Rapid Quantitative Test for Placental Growth Factor (PlGF). Version 26595eneu rev. C 2020\/10."},{"key":"10.1016\/bs.acc.2023.08.004_bib116","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028321","article-title":"Longitudinal circulating placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) concentrations during pregnancy in asian women: a prospective cohort study","volume":"9","author":"Ng","year":"2019","journal-title":"BMJ open."},{"key":"10.1016\/bs.acc.2023.08.004_bib117","doi-asserted-by":"crossref","first-page":"45762","DOI":"10.1038\/hr.2012.206","article-title":"Evaluation of a rapid and simple placental growth factor test in hypertensive disorders of pregnancy","volume":"36","author":"Gullai","year":"2013","journal-title":"Hypertens. Res."},{"key":"10.1016\/bs.acc.2023.08.004_bib118","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/AOG.0000000000001508","article-title":"Diagnostic biomarkers in women with suspected preeclampsia in a prospective multicenter study","volume":"128","author":"Duckworth","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3858\/emm.2012.44.1.025","article-title":"The discovery of placenta growth factor and its biological activity","volume":"44","author":"De Falco","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/bs.acc.2023.08.004_bib120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.preghy.2019.06.004","article-title":"Inter-manufacturer comparison of automated immunoassays for the measurement of soluble fms-like tyrosine kinase-1 and placental growth factor","volume":"17","author":"Cheng","year":"2019","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/bs.acc.2023.08.004_bib121","unstructured":"Thermoscientific B\u00b7R\u00b7A\u00b7H\u00b7M\u00b7S PlGF plus Kryptor. Instruction for Use (version r02en-ca)."},{"key":"10.1016\/bs.acc.2023.08.004_bib122","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.preghy.2017.02.005","article-title":"Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1\/PlGF ratio: diagnostic accuracy of the automated immunoassay Kryptor\u00ae","volume":"8","author":"Dr\u00f6ge","year":"2017","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/bs.acc.2023.08.004_bib123","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1515\/cclm-2018-1228","article-title":"Elecsys\u00ae and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?","volume":"57","author":"Stepan","year":"2019","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/bs.acc.2023.08.004_bib124","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.clinbiochem.2015.06.020","article-title":"Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia","volume":"48","author":"van Helden","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/bs.acc.2023.08.004_bib125","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0002-9378(00)70350-4","article-title":"Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of maternal-fetal medicine units","volume":"182","author":"Sibai","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib126","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.2147\/RMHP.S304040","article-title":"A review of research progress of pregnancy with twins with preeclampsia","volume":"14","author":"Wang","year":"2021","journal-title":"Risk Manag. Health Policy"},{"key":"10.1016\/bs.acc.2023.08.004_bib127","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029908","article-title":"Prevalence and risk of pre-eclampsia and gestational hypertension in twin pregnancies: A population-based register study","volume":"9","author":"Laine","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/bs.acc.2023.08.004_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/uog.14760","article-title":"Maternal serum sFlt-1\/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies","volume":"45","author":"Dr\u00f6ge","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib129","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/1471-0528.16518","article-title":"A prospective study of placental growth factor in twin pregnancy and development of a dichorionic twin pregnancy specific reference range","volume":"128","author":"Hayes-Ryan","year":"2021","journal-title":"BJOG: Int. J. Obstet. Gynaecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/HYPERTENSIONAHA.120.14957","article-title":"The prognostic value of angiogenic markers in twin pregnancies to predict delivery due to maternal complications of preeclampsia","volume":"76","author":"Binder","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/bs.acc.2023.08.004_bib131","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000514378","article-title":"Gestational age-specific reference ranges for the sFlt-1\/PlGF immunoassay ratio in twin pregnancies","volume":"48","author":"De La Calle","year":"2021","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/bs.acc.2023.08.004_bib132","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/uog.19178","article-title":"Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting","volume":"53","author":"Zeisler","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib133","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1186\/s13063-022-06652-8","article-title":"Placental growth factor repeat sampling for reduction of adverse perinatal outcomes in women with suspected pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2)","volume":"23","author":"Hurrell","year":"2022","journal-title":"Trials"},{"key":"10.1016\/bs.acc.2023.08.004_bib134","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ajog.2016.04.002","article-title":"Racial-ethnic differences in midtrimester maternal serum levels of angiogenic and antiangiogenic factors","volume":"215","author":"Yang","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/1471-0528.17296","article-title":"Effect of race on the measurement of angiogenic factors for prediction and diagnosis of pre-eclampsia","volume":"130","author":"Wright","year":"2023","journal-title":"BJOG: Int. J. Obstet. Gynaecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103780","article-title":"Clinical tools and biomarkers to predict preeclampsia","volume":"75","author":"MacDonald","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/bs.acc.2023.08.004_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11080530","article-title":"Do mass spectrometry-derived metabolomics improve the prediction of pregnancy-related disorders? Findings from a uk birth cohort with independent validation","volume":"11","author":"McBride","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/bs.acc.2023.08.004_bib138","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ije\/dyz098","article-title":"4-hydroxyglutamate is a novel predictor of pre-eclampsia","volume":"49","author":"Sovio","year":"2020","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/bs.acc.2023.08.004_bib139","article-title":"Expression and clinical significance of short-chain fatty acids in pregnancy complications","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/bs.acc.2023.08.004_bib140","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1080\/14767058.2019.1685964","article-title":"Maternal whole blood mrna signatures identify women at risk of early preeclampsia: A longitudinal study","volume":"34","author":"Tarca","year":"2021","journal-title":"J. Matern.-Fetal Neonatal Med."},{"key":"10.1016\/bs.acc.2023.08.004_bib141","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.placenta.2019.02.002","article-title":"The untapped potential of placenta-enriched molecules for diagnostic and therapeutic development","volume":"84","author":"Whigham","year":"2019","journal-title":"Placenta"},{"key":"10.1016\/bs.acc.2023.08.004_bib142","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.preghy.2019.02.003","article-title":"Circulating adrenomedullin mRNA is decreased in women destined to develop term preeclampsia","volume":"16","author":"Whigham","year":"2019","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/bs.acc.2023.08.004_bib143","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/jog.14397","article-title":"Levels of serum Hoxb3 and sFlt-1 in pre-eclamptic patients and their effects on pregnancy outcomes","volume":"46","author":"Zhou","year":"2020","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/bs.acc.2023.08.004_bib144","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40291-020-00468-5","article-title":"Circulating nucleic acids in maternal plasma and serum in pregnancy complications: are they really useful in clinical practice? A systematic review","volume":"24","author":"Carbone","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/bs.acc.2023.08.004_bib145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.placenta.2019.04.005","article-title":"The association between first trimester AFP to PAPP-A ratio and placentally-related adverse pregnancy outcome","volume":"81","author":"Hughes","year":"2019","journal-title":"Placenta"},{"key":"10.1016\/bs.acc.2023.08.004_bib146","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020302","article-title":"Circulating growth differentiation factor 15 is increased preceding preeclampsia diagnosis: implications as a disease biomarker","volume":"10","author":"Cruickshank","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/bs.acc.2023.08.004_bib147","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.placenta.2018.07.010","article-title":"Asymmetric dimethylarginine levels in preeclampsia - systematic review and meta-analysis","volume":"69","author":"N\u00e9meth","year":"2018","journal-title":"Placenta"},{"key":"10.1016\/bs.acc.2023.08.004_bib148","doi-asserted-by":"crossref","first-page":"43944","DOI":"10.18632\/oncotarget.16543","article-title":"Circulating asymmetric dimethylarginine and the risk of preeclampsia: a meta-analysis based on 1338 participants","volume":"8","author":"Yuan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/bs.acc.2023.08.004_bib149","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1753944715624853","article-title":"The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia","volume":"10","author":"Saleh","year":"2016","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/bs.acc.2023.08.004_bib150","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/uog.17561","article-title":"Prediction of severe pre-eclampsia\/HELLP syndrome by combination of sFlt-1, CT-pro-ET-1 and blood pressure: exploratory study","volume":"51","author":"Lind Malte","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.004_bib151","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3892\/etm.2022.11196","article-title":"New approaches in predicting and diagnosing preeclampsia: Congo red dot paper test (review)","volume":"23","author":"Petca","year":"2022","journal-title":"Exp. therapeutic Med."},{"key":"10.1016\/bs.acc.2023.08.004_bib152","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ajog.2008.07.006","article-title":"Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia","volume":"199","author":"Buhimschi","year":"2008","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242323000847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242323000847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T07:55:36Z","timestamp":1704268536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242323000847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780443192944"],"references-count":152,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2023.08.004","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}